泌尿學科

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Taiwan 54%
3. Neoplasms 53%
4. Prostate 52%
5. Apoptosis 48%
6. Urinary Bladder Neoplasms 46%
7. Carcinoma 42%
8. Neoplasm Metastasis 40%
9. Congenital bilateral aplasia of vas deferens 39%
10. Testosterone 37%
11. Androgens 35%
12. Arsenic 34%
13. Meta-Analysis 34%
14. Urinary Bladder 30%
15. Androgen Receptors 30%
16. Chronic Renal Insufficiency 29%
17. Autophagy 28%
18. Spermatozoa 27%
19. Down-Regulation 26%
20. Reactive Oxygen Species 26%
21. Therapeutics 26%
22. Non-Small Cell Lung Carcinoma 25%
23. Psidium 25%
24. Kidney 25%
25. Quercetin 23%
26. Castration 21%
27. Azoospermia 21%
28. mouse AR protein 20%
29. Cell Line 20%
30. ErbB Receptors 20%
31. Antrodia 20%
32. Genes 19%
33. Lung Neoplasms 19%
34. Erectile Dysfunction 19%
35. Spermatogenesis 19%
36. honokiol 19%
37. Hepatocellular Carcinoma 19%
38. Matrix Metalloproteinases 18%
39. Up-Regulation 18%
40. Prostate-Specific Antigen 18%
41. Proteins 18%
42. Prostatic Hyperplasia 18%
43. Growth 18%
44. Recurrence 18%
45. Sperm Retrieval 18%
46. MicroRNAs 18%
47. Inguinal Hernia 18%
48. Intracytoplasmic Sperm Injections 17%
49. Nanoparticles 17%
50. Systematic Reviews 17%
51. Serum 17%
52. Herniorrhaphy 17%
53. Renal Cell Carcinoma 16%
54. Mouth Neoplasms 16%
55. Population 16%
56. Gallic Acid 16%
57. Catenins 16%
58. Snails 16%
59. Kinetics 15%
60. Heterografts 15%
61. Genotype 15%
62. HL-60 Cells 15%
63. Acute Myeloid Leukemia 15%
64. Extracellular Signal-Regulated MAP Kinases 15%
65. Cell Death 15%
66. In Vitro Techniques 14%
67. Adenocarcinoma of Lung 14%
68. Testis 14%
69. Myeloid Cells 14%
70. Doxorubicin 14%
71. Carboplatin 14%
72. Alpinia 14%
73. Matrix Metalloproteinase 2 14%
74. ferulic acid 14%
75. Wounds and Injuries 13%
76. Cystic Fibrosis Transmembrane Conductance Regulator 13%
77. Epithelial-Mesenchymal Transition 13%
78. Squamous Cell Carcinoma 13%
79. bicalutamide 13%
80. Odds Ratio 13%
81. Curcumin 13%
82. JNK Mitogen-Activated Protein Kinases 12%
83. Inflammation 12%
84. Spermatic Cord Torsion 12%
85. Uropathogenic Escherichia coli 12%
86. Rutin 12%
87. Apigenin 12%
88. tricetin 12%
89. Urinary Tract 12%
90. Sperm Motility 11%
91. Anti-Inflammatory Agents 11%
92. Caspase 3 11%
93. Mortality 11%
94. Mutation 11%
95. Cohort Studies 11%
96. Platelet-Rich Plasma 11%
97. G1 Phase 11%
98. Survival 11%
99. Transitional Cell Carcinoma 11%
100. Liver 11%

Chemical Compounds

1. Androgen 20%
2. Collagen 18%
3. Protein 18%
4. Alginate 15%
5. Marker 14%
6. Nanoparticle 14%
7. Cell Death 13%
8. Drug 13%
9. Prostaglandin E1 13%
10. Quercetin 12%
11. Nifedipine 11%
12. Tricetin 11%
13. Bioactivity 11%
14. Antigen 10%
15. Reactive Oxygen Metabolite 10%
16. Cantharidin 10%
17. Bicalutamide 10%
18. Gallic Acid 9%
19. Antiinflammatory 9%
20. Propofol 9%
21. Plasma 8%
22. Iron Oxide 8%
23. Hypolipidemic 8%
24. Oxidative Stress 8%
25. Rutin 8%
26. Smoke 8%
27. Percutaneous 8%
28. Antioxidant Agent 8%
29. Biocompatible Material 8%
30. Dioxygen 8%
31. Autophagy Inhibitor 8%
32. Cisplatin 7%
33. Essential Oil 7%
34. Chain Reaction 7%
35. Amount 7%
36. Ferulic Acid 7%
37. Meso Porosity 6%
38. Bioreactors 6%
39. N-Butyl-N-(3-Carboxypropyl)nitrosamine 6%
40. Drug Carrier 6%
41. Polyphenol 6%
42. Weight 6%
43. Testosterone 5%
44. Apoptosis Inhibitor 5%
45. Genetic Polymorphism 5%
46. Dose 5%
47. Inducer 5%
48. 3-Methyladenine 5%
49. Tomatidine 5%
50. Enzalutamide 5%
51. Environmental Carcinogen 5%
52. Glucose 5%
53. Cord 5%
54. Western Blotting 5%
55. Lipopolysaccharide 5%
56. Intracranial 5%
57. Reduction 5%
58. Enterodiol 5%
59. Diallyl Trisulfide 5%
60. Torsion 5%
61. Withaferin A 5%
62. Dihydromyricetin 5%
63. Monocrotaline 5%
64. Rutinoside 5%
65. Pterostilbene 5%
66. Calcium Channel Blocker 5%
67. Microsphere 5%
68. Molecule 5%
69. Secoisolariciresinol 5%
70. Adipogenic 5%
71. Lipid 5%
72. Antitumor 5%